COVID-19
Top in ID: Doxy-PEP for STI prevention; SARS-CoV-2 antigens active months after infection
Multiple studies presented at the Conference on Retroviruses and Opportunistic Infections, or CROI, supported doxycycline post-exposure prophylaxis for the prevention of sexually transmitted infections.
Continuous Medicaid eligibility during COVID-19 increased postpartum coverage
Continuous Medicaid eligibility during COVID-19 significantly reduced postpartum loss of insurance, but was not tied to health care use, contraceptive use, breastfeeding or depressive symptoms in early postpartum, researchers reported.
Adults who survive COVID-19-AKI may have fewer major adverse kidney events
Adults who survive COVID-AKI hospitalization may experience fewer major adverse kidney events and lower mortality than patients with AKI tied to with other illnesses, according to published data.
Mortality for high-risk gastrointestinal cancers ‘largely unaffected’ by COVID-19 pandemic
High-risk gastrointestinal cancer diagnoses declined sharply during the first 3 months of the COVID-19 pandemic in 2020, but they returned to previous levels by the middle of the year, according to results published in JAMA Network Open.
Top in ID: New COVID-19 isolation guidance; booster shots for older adults
The CDC updated its COVID-19 isolation guidance for the first time in 2 years, saying that people with COVID-19 no longer have to isolate for 5 days if they are showing certain signs of improvement.
Prolonged SARS-CoV-2 infections impact quarter of immunocompromised patients
Approximately 25% of patients with COVID-19 who are immunocompromised remain positive for the disease 21 days or more from initial onset, according to data published in The Lancet Microbe.
Patients with prior COVID-19 at higher risk for new-onset autoimmune inflammatory disease
Patients with a history of COVID-19 demonstrate a higher risk for new-onset autoimmune inflammatory rheumatic diseases, with greater infection severity linked to greater risk, according to data published in the Annals of Internal Medicine.
SARS-CoV-2 protein detectable in COVID-19 patients up to 14 months after illness
DENVER — SARS-CoV-2 antigens persist in patients with COVID-19 for months to years after infection, according to data presented at the Conference on Retroviruses and Opportunistic Infections.
Latest COVID-19 vaccines reduce hospitalization risk by around half
The latest COVID-19 vaccines reduce the risk for hospitalization or visits to an ED or urgent care by around 50%, according to interim data published in MMWR.
CDC: People with COVID-19 no longer have to isolate for 5 days
The CDC said Friday that people with COVID-19 no longer have to isolate for 5 days if they are showing certain signs of improvement — the first time in more than 2 years that the guidance has been updated.